Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 2: Answers to questions about Epoetin alfa.
N
N
Gallagher
D
D
Latham
B
B
Prowant
L
L
Binkley
R
R
Chapin
L
L
Erlich
E
E
Nichols
D
D
Osborne
D001794:Blood Pressure / Q000187:drug effects; D004274:DNA, Recombinant / Q000627:therapeutic use*; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000097:blood; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D004274:DNA, Recombinant; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron